Matteo Lambertini, MD, PhD, University of Genova IRCCS Ospedale Policlinico San Martino

Articles

Breast Cancer Management: Future Directions in Fertility Preservation

July 19th 2023

Closing out their discussion on fertility preservation in breast cancer, Matteo Lambertini, MD, PhD, and Virginia Kaklamani, MD, DSc, look toward unmet needs and future evolutions in the treatment landscape and offer advice for community physicians.

Timing Fertility Preservation in Patients With Breast Cancer Undergoing Surgery

July 19th 2023

Expert oncologists Matteo Lambertini, MD, PhD, and Virginia Kaklamani, MD, DSc, review fertility preservation strategies in the context of patients with breast cancer undergoing surgery.

Treatment Guidelines on Fertility Preservation in Breast Cancer

July 12th 2023

Focused discussion on treatment guidelines and recommendations for fertility preservation while treating premenopausal patients with breast cancer.

Monitoring Patients With Breast Cancer Receiving OFS

July 12th 2023

A brief review of monitoring, response assessment, and treatment modification strategies used for patients with breast cancer undergoing OFS. .

Factors Informing the Selection and Use of OFS in Breast Cancer

July 5th 2023

Expert perspectives on the appropriate selection and use of OFS in premenopausal patients with breast cancer.

Data From the SOFT and TEXT Trials: Combination Therapy With OFS in Breast Cancer

July 5th 2023

Matteo Lambertini, MD, PhD, and Virginia Kaklamani, MD, DSc, reflect on the SOFT and TEXT clinical trials to elucidate combination treatment strategies with ovarian function suppression (OFS).

Fertility Preservation in Breast Cancer: Use of GnRH Agonists

June 28th 2023

Comprehensive insight to available gonadotropin-releasing hormone (GnRH) agonists in breast cancer and the role they play when thinking about fertility preservation.

Overview of Fertility Preservation Strategies in Breast Cancer Care

June 28th 2023

Key opinion leaders on breast cancer management provide a broad overview of fertility preservation strategies available to patients.

Addressing Chemotherapy-Induced Menopause in Patients With Breast Cancer

June 21st 2023

Focused discussion on the incidence of chemotherapy-induced menopause in patients receiving treatment for their breast cancer.

Prevalence of Premenopausal Patients With Breast Cancer

June 21st 2023

Expert oncologists Matteo Lambertini, MD, PhD, and Virginia Kaklamani, MD, DSc, reflect on the subset of patients with breast cancer who are premenopausal and how that impacts their approach to disease management.

Dr. Lambertini on the Effect of GnRH Agonists on Ovarian Function in Breast Cancer

May 11th 2022

Matteo Lambertini, MD, discusses how GnRH agonists work to preserve ovarian function in premenopausal patients with breast cancer.

Dr. Lambertini on Preserving Ovarian Function and Fertility During Chemotherapy Treatment

October 6th 2015

Matteo Lambertini, MD, Department of Medical Oncology, U.O. Oncologia Medica A, Hospital San Martino, Genova, Italy, discusses the use of luteinizing hormone-releasing hormone agonists (LHRHa) during chemotherapy to preserve ovarian function and fertility in patients with breast cancer.